Bosh sahifaBAVA • CPH
add
Bavarian Nordic A/S
Yopilish kursi
199,25 kr
Kunlik diapazon
189,40 kr - 198,00 kr
Yillik diapazon
143,40 kr - 300,00 kr
Bozor kapitalizatsiyasi
15,71 mlrd DKK
Oʻrtacha hajm
290,98 ming
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
CPH
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (DKK) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 1,36 mlrd | -0,95% |
Joriy xarajat | 486,03 mln | -22,90% |
Sof foyda | 70,49 mln | 120,69% |
Sof foyda marjasi | 5,17 | 120,89% |
Har bir ulushga tushum | 0,90 | -67,86% |
EBITDA | 250,46 mln | -34,15% |
Amaldagi soliq stavkasi | 2,71% | — |
Balans
Jami aktivlari
Jami passivlari
| (DKK) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 1,87 mlrd | 24,16% |
Jami aktivlari | 13,95 mlrd | 4,10% |
Jami passivlari | 3,26 mlrd | -19,68% |
Umumiy kapital | 10,69 mlrd | — |
Tarqatilgan aksiyalar | 78,32 mln | — |
Narxi/balansdagi bahosi | 1,46 | — |
Aktivlardan daromad | 1,66% | — |
Kapitaldan daromad | 2,19% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (DKK) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 70,49 mln | 120,69% |
Operatsiyalardan naqd pul | -71,63 mln | -123,41% |
Sarmoyadan naqd pul | 150,15 mln | 249,75% |
Moliyadan naqd pul | 109,92 mln | 1 051,60% |
Naqd pulning sof oʻzgarishi | 180,29 mln | -10,03% |
Boʻsh pul | -914,47 mln | -666,57% |
Haqida
Bavarian Nordic A/S is a fully integrated biotechnology company focused on the development, manufacturing and commercialization of vaccines. The company is headquartered in Hellerup, Denmark, with manufacturing facilities in Kvistgård, Denmark and Thörishaus near Bern, Switzerland. The company has research and development facilities in Martinsried, Germany and San Diego, California, as well as offices in Zug, Switzerland, and Morrisville, North Carolina. The company uses viral vectors and virus-like particles in its research and development. Wikipedia
CEO
Tashkil etilgan
1-iyl, 1992
Xodimlar soni
1 609
